Clinical Trials Logo

Off-Label Use clinical trials

View clinical trials related to Off-Label Use.

Filter by:
  • None
  • Page 1

NCT ID: NCT02954679 Completed - Clinical trials for Substance-related Disorder

French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students

ENQUETE-COSYS
Start date: January 23, 2017
Phase:
Study type: Observational

This descriptive and declarative study will help to find out consumption rates, all psychoactive substances taken together, among 18-25 year olds. More specifically, it will allow assessment of the extent of the cognitive enhancement phenomenon among students in France (including study of misuse of methylphenidate (MPH) and modafinil in improvement of cognitive performance).

NCT ID: NCT02654379 Completed - Off-Label Use Clinical Trials

Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe

Start date: December 18, 2015
Phase:
Study type: Observational

This study is to characterize the indications for which rituximab is being used and to evaluate the use of the Patient Alert Card (PAC) in participants receiving the medication for non-oncology conditions at infusion centers. The study involves the retrospective chart review of rituximab users' medical records in non-oncology indications as well as a survey to collect information on participant characteristics, and will include questions about participant knowledge on the risk of infections, participant receipt and review of the PAC, and any actions the participant has taken as a result of receiving the PAC.